Table 1

Clinical characteristics of men according to weekly alcohol intake

Alcohol intake, drinks* per week
All menAbstainer<1414–2021–27>27
Subjects, n1999431025241234456
Drinks per week (median, (10%; 90%))12.5 (2.1–40.7)N/A6.9 (1.5–11.9)18.4 (14.9–20.7)23.8 (21.4–26.3)38.8 (28.6–64.7)
Years of follow-up (median (10%; 90%))4.9 (1.0–11.3)5.3 (1.8–11.5)5.0 (1.0–11.2)4.7 (1.0–11.2)4.9 (0.9–11.6)4.8 (1.1–11.4)
Age, years (median (10%; 90%))66.5 (58.8–73.9)66.8 (60.0–73.3)66.7 (59.1–74.4)66.5 (58.8–73.7)66.5 (58.8–73.8)66.4 (58.5–73.5)
 Age ≥75 years6.74.97.76.66.05.0
 Age 65–74 years53.462.852.752.754.353.9
Heart failure7.511.68.16.25.67.2
Hypertension27.720.929.127.825.626.1
Diabetes15.318.615.017.411.516.4
Previous
 Ischaemic stroke6.47.07.05.86.85.0
 Transient ischaemic attack3.00.03.32.64.32.2
 Arterial thromboembolism0.62.30.70.00.00.9
Haemorrhagic stroke1.00.00.51.70.91.5
Vascular disease
 Previous myocardial infarction13.318.615.111.69.411.4
 Aortic plaque0.42.30.40.40.00.2
 Peripheral artery disease4.67.03.55.04.76.4
VKA treated21.723.321.222.820.522.8
CHADS2 (mean)0.830.810.860.820.740.81
 050.544.149.349.457.750.4
 128.034.928.231.122.228.3
 ≥221.520.922.419.520.121.3
CHA2DS2-VASc=024.920.924.823.226.125.9
  • Data are percentages unless otherwise stated.

  • *One drink corresponds to 12 g of pure alcohol.

  • VKA, vitamin K antagonist.